Pharmaceuticals, Policy and Law

Titel Veröffentlichungsdatum Sprache Zitate
Directive 2004/27/EC of the European Parliament and of the Council of 31 March 20042009/01/016
Directive 2001/83/EC of the European Parliament and of the Council of 6 November 20012009/01/016
Article 15, Directive 2011/24/EU of the European Parliament and of the Council of 9 March 2011 on the application of patients' rights in cross-border healthcare2011/01/013
Directive 2002/98/EC of the European Parliament and of the Council of 27 January 20032009/01/012
Healthcare information technology in Italy, critiques and suggestions for European digitalization2018/10/172
The prevention and detection of corruption in pharmaceutical companies2017/04/012
Breaking New Ground: The WTO Agreement on Trade Facilitation2016/10/091
Compulsory licensing: Procedural requirements under the TRIPS agreement2016/10/101
The global response to the threat of antimicrobial resistance and the important role of vaccines2016/11/161
Council Directive 89/105/EEC of 21 December 1988 relating to the transparency of measures regulating the prices of medicinal products for human use and their inclusion in the scope of national health insurance systems2011/01/011
Council Directive 2000/43/EC of 29 June 2000 implementing the principle of equal treatment between persons irrespective of racial or ethnic origin2011/01/011
Patient involvement in HTA: What added value?2011/01/011
Ethics and compliance in global pharmaceutical industry marketing and promotion: The role of the IFPMA and self-regulation2016/10/091
An assessment of health and work productivity measurement in employer settings2012/01/01
U.S. healthcare reform and the pharmaceutical market: Projections from institutional history2013/01/01
EMA initiatives for innovation2010/01/01
Registration dossier for radiopharmaceutical products2015/01/01
Rare diseases treated by plasma proteins2009/01/01
Erratum2010/01/01
The role of the pharmacist in the determination of pharmacotheraphy costs: Ischemic cardiopathy patients with smoking habits2010/01/01
Challenges and opportunities related to health promotion in community pharmacies: Obstacles and professional perspectives2014/01/01
Data protection and market exclusivities for pharmaceuticals in the EU2014/01/01
Homeopathic medicines2015/01/01
Balance between new treatment opportunities and public health expenditure control: The Regulatory Agency role2010/01/01
Homeopathy: The lost of credibility of the Institutions2011/01/01
Counterfeit medicines as global treat2010/01/01
Iberoamerican pharmaceutical academies2014/01/01
A single European pharmaceutical market: Does maximum harmonization enhance medicinal product innovation?2013/01/01
Erratum2014/01/01
Primary immunodeficiencies2009/01/01